Episode 157: Biomarker Testing Improves Outcomes for Patients With Non-Small Cell Lung Cancer

May 28, 2021

ONS member Beth Sandy, MSN, CRNP, thoracic oncology nurse practitioner at the University of Pennsylvania Abramson Cancer Center in Philadelphia, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss key considerations for oncology nurses regarding biomarker testing for patients with non-small cell lung cancer. This podcast episode is sponsored by Amgen. 

Episode Notes 

Check out these resources from today’s episode:  

• NCPD contact hours are not available for this episode.
• Oncology Nursing Podcast Episode 134: Nurse Innovators Increase Access to Biomarker Testing During ONS Hackathon 
• ONS Voice article: An Oncology Nurse’s Primer on Genomics and Biomarker Terminology 
• ONS Voice article: Harnessing the Power of Genes 
• ONS Voice article: Targeted Therapies Are Transforming the Treatment of Non-Small Cell Lung Cancer 
• Clinical Journal of Oncology Nursing article: Genetic Biomarkers: Implications of Increased Understanding and Identification in Lung Cancer Management 
• ONS discussion tool: Biomarker Testing in Non-Small Cell Lung Cancer 
• ONS video: What Are Biomarkers? 
• ONS’s guide to biomarker testing 

To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email [e-mail].